Absorbent article

A bilayer absorbent structure with strategic antibacterial fluid distribution enhances absorption and antibacterial properties, addressing issues of leakage and skin irritation in absorbent devices.

SA1120262266A1Pending Publication Date: 2026-10-05UNI CHARM CORP
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
SA1120262266
Authority / Receiving Office
SA · SA
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-03-17
Publication Date
2026-10-05

AI Technical Summary

Technical Problem

Existing absorbent devices face challenges in achieving effective antibacterial properties while maintaining efficient fluid absorption and preventing lateral leakage, often leading to skin irritation and reduced absorption rates due to the distribution of antibacterial fluids.

Method used

A bilayer absorbent structure with a central section coated with a larger quantity of antibacterial fluid and outer sides with minimal or no coating, allowing fluid to diffuse and be absorbed by minimally coated superabsorbent polymers, enhancing absorption and preventing leakage.

Benefits of technology

The solution ensures broad-area absorption, reduces skin irritation, and improves fluid diffusion and retention, while maintaining antibacterial efficacy and preventing lateral leakage.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 34348460-A569-40B5-AA16-D316B32D0911
    Figure 34348460-A569-40B5-AA16-D316B32D0911
  • Figure 57E2756A-6533-431F-8ABD-D1B6727822C2
    Figure 57E2756A-6533-431F-8ABD-D1B6727822C2
  • Figure CF5119C6-3A00-4CD2-B823-00D75FDC0117
    Figure CF5119C6-3A00-4CD2-B823-00D75FDC0117
Patent Text Reader

Abstract

The present invention relates to an absorbent article comprising: an antibacterial liquid containing an antibacterial agent and an organic solvent; and a highly water-absorbent polymer. The absorbent article may exhibit both antibacterial and absorbent performance. The absorbent article (1) comprises: an absorbent body (4) supported by a highly water-absorbent polymer; and an antibacterial liquid containing an antibacterial agent and an organic solvent. The antibacterial liquid coats the highly water-absorbent polymer placed in the central section on the transverse side of the absorbent body (4). The antibacterial liquid does not coat the highly water-absorbent polymers placed outside the central section, on either side of the transverse side of the absorbent body (4). Figure 1
Need to check novelty before this filing date? Find Prior Art

Description

The disclosure of the present invention relates to the following aspects. [Side 1] It has a longitudinal direction, a transverse direction, and a thickness direction that are alternately perpendicular and includes an absorbent body that carries a superabsorbent polymer. It also includes an antibacterial liquid that contains an antibacterial agent and an organic solvent, where the antibacterial liquid is present in a larger quantity covering the superabsorbent polymer placed in a central section in the transverse direction of the absorbent body, and in a smaller quantity covering the superabsorbent polymer placed on both outer sides of the central section in the transverse direction of the absorbent body. In the current absorbent device, a larger quantity of antibacterial fluid covers the superabsorbent polymer located in the central transverse section of the absorbent body, while a smaller quantity (ideally, zero coverage) covers the superabsorbent polymer located on the outer sides of the central transverse section. Consequently, the body fluid in the central transverse section comes into contact with the antibacterial fluid covering the superabsorbent polymer, allowing the antibacterial agent in the antibacterial fluid to exert its antibacterial properties. Furthermore, because the superabsorbent polymer in the central transverse section of the absorbent body is coated with antibacterial fluid, the absorption rate of the body fluid by the superabsorbent polymer in the central transverse section may be reduced. This prevents absorption of the body fluid and allows it to diffuse easily to the outer sides of the central transverse section. In particular, the diffusion of the body fluid to the outer sides of the central transverse section may be improved.The dispersed fluid can be easily absorbed by the superabsorbent polymer applied to the outer sides of the central section, which is minimally coated with the antibacterial solution. This allows the absorbent to be used over a wide area and prevents lateral leakage, where fluid would otherwise leak from the peripheral sections of the absorbent. Therefore, an absorbent incorporating both an antibacterial solution and a superabsorbent polymer achieves both antibacterial and absorbent performance. [Side 2] The absorbent device, according to side 1, also includes an upper layer absorbent body that includes the absorbent body and a lower layer absorbent body 511 positioned on the side furthest from the skin in the direction of thickness relative to the upper layer absorbent body. The current absorbent also includes an upper layer antibody, the absorbent described above, and a lower layer antibody. As the body fluid passes through the upper layer antibody, it comes into contact with the antibacterial liquid coating the superabsorbent polymer, thus enabling the antibacterial agent in the antibacterial liquid to exert its antibacterial properties. Furthermore, because the superabsorbent polymer in the central section of the upper layer absorbent is coated with an antibacterial liquid, the absorption of the body fluid by the superabsorbent polymer in the central section can be prevented. Therefore, the body fluid may readily migrate to the lower layer absorbent. In this case, as the body fluid migrates to the lower layer absorbent, the antibacterial liquid gradually migrates to the lower layer absorbent, thereby increasing the amount of antibacterial liquid in the lower layer absorbent. Specifically, the antibacterial properties of the lower layer absorbent increase in proportion to the amount of body fluid.Not only during the initial absorption of body fluid, but also during subsequent absorption processes, the absorption of body fluid is prevented by the superabsorbent polymer in the central section of the absorbent body with the top layer. This improves the rewetting capability of the absorbent. In the absorbent body with the top layer, the superabsorbent polymer on both outer sides of the central section, which is minimally coated with antibacterial fluid, generally maintains the original absorption performance of the superabsorbent polymer. Therefore, the body fluid can be absorbed into the superabsorbent polymer, thus further preventing lateral leakage of the body fluid. [Side 3] The absorbent tool according to side 2, where there is a portion of the antibacterial liquid in the absorbent body in the lower layer, and the amount of antibacterial liquid in the absorbent body in the upper layer is greater than the amount of antibacterial liquid in the absorbent body in the lower layer. In the current absorbent, a portion of the antibacterial fluid is located in the lower layer of the absorbent body, while the amount of antibacterial fluid in the upper layer is greater than the amount in the lower layer. Because of the presence of the antibacterial fluid, albeit in a small quantity, in the lower layer of the absorbent body, its antibacterial properties can be efficiently demonstrated from the initial absorption of the body fluid. [Side 4] The absorbent tool, according to side 2 or 3, includes the absorbent body in the top layer, in a horizontal projection, a region of superabsorbent polymer where the superabsorbent polymer is present and a region free of superabsorbent polymer where the superabsorbent polymer is absent. The region free of superabsorbent polymer includes a compressed section in which the absorbent body in the top layer is compressed in the direction of thickness. In the current absorbent device, the upper absorbent body, in a horizontal view, comprises a region containing a superabsorbent polymer and a region free of the superabsorbent polymer. The region free of the superabsorbent polymer includes a compressed section. Therefore, the body fluid can be transferred from the upper absorbent body to the lower absorbent body through the compressed section without being impeded by the superabsorbent polymer. This enhances the fluid transfer properties from the upper absorbent body to the lower absorbent body, potentially preventing further lateral leakage of the body fluid. [Side 5] The absorbent tool is classified according to any of the aspects from 2 to 4, where at least the lower absorbent body, the upper absorbent body, and the lower absorbent body contain pulp fibers, and the amount of pulp fibers in the lower absorbent body is greater than the amount of pulp fibers in the upper absorbent body. In the current absorbent device, the lower layer absorbent body contains a greater number of core fibers than the upper layer absorbent body. Consequently, the upper layer absorbent body contains fewer core fibers, which readily trap body fluid around the antibacterial agent (superabsorbent polymer). Therefore, the antibacterial effect of the antibacterial agent may be prolonged in the upper layer absorbent body. The lower layer absorbent body contains more core fibers, allowing for faster absorption and easier retention of body fluid. In this case, the body fluid can be retained by the upper layer absorbent body, which is physically separated from the body, thus potentially preventing skin irritation. [Side 6] The absorbent tool is arranged according to any of the sides from 2 to 5, where the antibacterial liquid is present in a larger quantity covering the superabsorbent polymer placed in the central section in the longitudinal direction of the absorbent body, and in a smaller quantity covering the superabsorbent polymer placed in front of the central section in the longitudinal direction of the absorbent body. In the current absorbent device, the antibacterial fluid is present in greater quantities covering the superabsorbent polymer located in the central longitudinal section of the absorbent body (top layer), and in less quantities (ideally, zero coverage) covering the superabsorbent polymer located anterior (ventral side) of the central longitudinal section of the absorbent body (top layer). Accordingly, absorption of body fluid by the superabsorbent polymer in the central longitudinal section is prevented, while body fluid may be more readily absorbed by the superabsorbent polymer on the ventral side compared to the central longitudinal section, which is minimally covered with the antibacterial fluid. In the ventral (anterior lateral longitudinal) section of the body, which is likely to come into direct or indirect contact with the absorbent body (top layer), the antibacterial fluid is absent from the absorbent body (top layer). Consequently, contact between the antibacterial fluid and the body may be prevented, and skin irritation caused by the antibacterial agent in the antibacterial fluid may be prevented. [Side 7] The absorbent device, according to any of the protection elements 2 to 6, includes an absorbent body with an upper layer, a skin-side section placed on the skin-side in the direction of thickness, and a distal section placed on the distal side of the skin in relation to the skin-side section in the direction of thickness. The water retention rate of the skin-side section is less than the water retention rate of the distal section. In the current absorbent device, the water retention rate of the skin-side portion of the top-layer absorbent body is relatively low. Therefore, the skin-side portion, which is the upper surface of the top-layer absorbent body, can be conveniently kept dry (smooth). The water retention rate of the distal portion of the top-layer absorbent body is relatively high. Consequently, the superabsorbent polymer coated with an antibacterial agent can make sufficient contact with the body fluid on the distal portion, which is the back surface of the top-layer absorbent body, potentially enhancing the antibacterial performance of the antibacterial agent. [Side 8] The absorbent tool is according to any of the aspects 2 to 7, where the absorbent body in the lower layer includes an absorbent core, a skin-side thin core wrapping layer covering the skin side in the direction of the absorbent core thickness, and a skin-side thin core wrapping layer covering the skin-side in the direction of the absorbent core thickness. The skin-side thin core wrapping layer and the skin-side thin core wrapping layer are made of uneven, crumpled paper, and the degree of unevenness in the skin-side thin core wrapping layer is less than the degree of unevenness in the skin-side thin core wrapping layer. In the current absorbent, the degree of unevenness in the skin-side thin pulp wrapping layer (made of uneven, crumpled paper) of the lower layer of the absorbent body is relatively low. This allows for improved fluid diffusion in the plane direction of the skin-side thin pulp wrapping layer. Additionally, it increases the contact area between the upper layer of the absorbent body and the skin-side thin pulp wrapping layer, as well as the contact area between the skin-side thin pulp wrapping layer and the absorbent pulp. Accordingly, during use, the fluid released from the absorbent body and transferred from the upper layer to the skin-side thin pulp wrapping layer can diffuse in the plane direction of the skin-side thin pulp wrapping layer and subsequently be transferred to the absorbent pulp. Increasing the degree of unevenness in the skin-side thin pulp wrapping layer of the crumpled paper can easily distort the skin-side thin pulp wrapping layer.Even if the absorbent material expands and contracts due to the wearer's body movements during use, the outer layer of the absorbent core may follow this expansion and contraction, thus reducing tearing. In this case, because the unevenness of the outer layer of the absorbent core absorbs the external force resulting from body movements, the external force acting on the outer layer of the absorbent core can be reduced, and consequently, tearing of the outer layer of the absorbent core can be minimized. Here, the absorbent device will be described according to the models using the example of a light incontinence pad. However, the type of absorbent device is not limited to this example and may include other types of absorbent devices without exceeding the scope of the present invention. Examples of such absorbent devices include tape-type diapers, incontinence pads, sanitary napkins, and panty liners. Figures 1 and 2 are schematic representations of the construction of a mild incontinence pad (Figure 1) according to the models. Figure 1 is a horizontal projection showing a construction example of a mild incontinence pad according to the models. Figure 2 is a cross-sectional view along the CW-CW line in Figure 1. The mild incontinence pad 1, in its unfolded state as shown in Figure 1, has alternating perpendicular longitudinal directions (L), transverse directions (W), and thickness directions (T). It has a longitudinal centerline (CL) passing through the center in the transverse direction (W) and extending in the longitudinal direction (L), and a transverse centerline passing through the center in the longitudinal direction (L) and extending in the transverse direction (W). The direction and side closest to the longitudinal centerline are known as the inward direction and the inward part, respectively, in the transverse direction (W), and the direction and side furthest from it are known as the outward direction and the outward part, respectively, in the transverse direction (W). The direction and side closest to the transverse centerline are known as the inward direction and the inward part, respectively, in the longitudinal direction (L), and the direction and side furthest from it are known as the outward direction and the outward part, respectively, in the longitudinal direction (L).The side facing the edge of the Light Incontinence Pad 1 opposite the wearer's abdomen (the edge on the abdomen) in the longitudinal direction L is referred to as the front side in the longitudinal direction L, and the side facing the edge of the Disposable Diaper 1 opposite the wearer's dorsal side (the edge on the dorsal side) is referred to as the back side in the longitudinal direction L. "Plane projection" refers to viewing the Light Incontinence Pad 1 unfolded on a plane encompassing a longitudinal direction L and a transverse direction W from above in the thickness direction T. "Flat figure" refers to the figure as seen in the plane projection. The "plane direction" refers to any direction within the plane that includes a transverse direction W and a longitudinal direction L. The "skin side" and "distant side" refer to the side that is relatively closest and the side that is relatively farthest from the wearer's skin surface, respectively, in the thickness direction T when the wearer is wearing a light urinary incontinence pad 1. The direction along the longitudinal direction L is not limited to the direction parallel to the longitudinal direction L, and includes a range of ±30° with respect to the longitudinal direction L.The direction along the transverse direction W is not limited to the direction parallel to the transverse direction W, and includes a range of ±30° with respect to the transverse direction W. These definitions are commonly applied not only to the light incontinence pad 1 but also to the absorbent body in the light incontinence pad 1 and any material placed in it. As illustrated in Figure 1, the Light Incontinence Pad 1, in a horizontal projection, has a rectangular shape extending longitudinally (L) with short sides extending transversely (W), and a shape where the two longitudinal edges (L) extend outwards against the short sides in a circular arc. However, in the current model, the shape of the Light Incontinence Pad 1 is not limited to this example; it simply needs to be such that the length in the longitudinal direction (L) is longer than the length in the transverse direction (W). Examples of this shape include the rectangle, the rectangle with rounded corners, the oval, the pumpkin, and the hourglass. As illustrated in Figure 2, the mild incontinence pad 1 consists of a thin top layer 2, placed on the skin side and characterized by fluid permeability; a thin back layer 3, placed on the side opposite the skin and characterized by fluid impermeability; and an absorbent body 4, positioned between the thin top layer 2 and the thin back layer 3, which absorbs and retains fluid. Examples of materials used for the thin top layer 2 include permeable nonwoven and woven fabrics, synthetic resin films with permeable pores, and combinations of the same or different types. Examples of materials for the thin back layer 3 include nonwoven and porous fabrics, synthetic resin films with interstitial air holes, and combinations of the same or different types. A thin permeable diffusion layer may be available, placed between the thin top layer 2 and the absorbent body 4, which diffuses fluid in a plane direction. The absorbent material 4 includes superabsorbent polymers and may contain pulp fibers. An absorbent 4 may consist of a thin, fluid-permeable core wrapping layer encasing a superabsorbent polymer (and pulp fibers). As shown in Figure 2, an absorbent 4 may have a bilayer structure (top layer 11 and bottom layer 12 absorbent (described below)), a single-layer structure (e.g., top layer 11 and bottom layer 12 absorbent), or a multilayer structure with three or more layers. An absorbent 4 with a relatively thin, single-layer structure is referred to as a thin absorbent layer, and specifically, if its main material is a superabsorbent polymer, it may be referred to as a thin superabsorbent polymer layer. In the current model, the surface on the distal side of the top thin layer 2 and the surface on the dermal side of the absorbent body 4 are mutually correlated, and the surface on the distal side of the absorbent body 4 is mutually correlated with the surface on the dermal side of the back thin layer 3. The peripheral sections of the surface on the distal side of the top thin layer 2 and the peripheral sections are mutually correlated with the surface on the dermal side of the back thin layer 3. Examples of thin top layers include a flat, uneven thin layer. However, thin top layers are not limited to this example; any thin layer suitable for use as a thin top layer for absorbent instruments is sufficient. A thin top layer might, for instance, consist of a variety of raised sections extending longitudinally (L) and spaced apart transversely (W), with a variety of recessed sections positioned between these raised sections. Alternatively, it could be a thin layer in which a variety of roughly circular raised sections are arranged in a mottled pattern in the horizontal plane. The type of nonwoven fabric for the top thin layer 2 and the back thin layer 3 was not specified as long as nonwoven fabrics could be used for absorbent devices, and examples include meltblown nonwovens, spun-spun synthetic nonwovens, air-exposed nonwovens, and air-permeable nonwovens. Nonwoven fabrics are not specifically defined as long as they can be used for absorbents; examples include synthetic resin fibers and pulp fibers. Synthetic resins are not specifically defined as long as they can be used as absorbent materials; examples include olefin-based resins, such as polyethylene and polypropylene; polyamide-based resins, such as 6-nylon and 6,6-nylon; and polyester-based resins, such as polyethylene terephthalate and polybutylene terephthalate. Pulp fibers are not specifically defined as long as they can be used as absorbent materials; cellulose-based fibers are given as an example. As examples of cellulose-based fibers, those from wood pulp, interlocking pulp, non-wood pulp, regenerated cellulose, and semi-synthetic cellulose are given as an example. The specific types of synthetic resin membranes for the thin top layer 2 and thin back layer 3 were not defined, provided the membranes could be used as absorbent membranes. Examples include the well-known membrane materials. The specific synthetic resin membrane material was not defined, provided the material could be used as an absorbent material. Examples include the synthetic resins described above. The specific type of superabsorbent polymer in an absorbent body (4) is not defined, as long as the polymer is capable of absorbing and retaining water. Examples include polyacrylate-based, polysulfonate-based, and maleic anhydride-based superabsorbent polymers. The core fiber type is as described above. Examples of core fiber content in an absorbent body (4) include ranges from 0 to 90% of the superabsorbent polymer mass. As illustrated in Figure 2, in the current prototype, the mild incontinence pad 1 includes an additional pair of thin side layers 7; two linear elastic members 8a and 8b; a thin outer layer 9; and a fixation section 10. The pair of thin side layers 7 is positioned to cover the surface on both sides in the transverse W direction of the thin top layer 2. In the pair of thin side layers 7, the inner sections in the transverse W direction form a pair of leak barrier walls extending in the longitudinal L direction. The leak barrier wall pair is folded so that it can stand perpendicular to the surface on both sides in the transverse W direction of the thin top layer 2, with the inner edges in the transverse W direction being free ends. The two linear elastic members 8a are linear elastic bodies extending along the longitudinal L direction near the free ends of the leak barrier wall pair. The linear flexible members 8a work to shrink the inner edge in the transverse direction W of the leakage barrier walls, making the leakage barrier walls stand and include assembled sections.The outer thin layer 9 is attached to the surface on the distal side of the back thin layer 3, and at its peripheral sections, it is reciprocally attached to the pair of lateral thin layers 7. The linear elastic members 8b are linear elastic bodies that extend along the longitudinal direction L between the outer thin layer 9 and the pair of lateral thin layers 7 at their terminal sections in the transverse direction W of the outer thin layer 9 and the pair of lateral thin layers 7. The linear elastic members 8b retract the outer edges in the transverse direction W of the mild incontinence pad 1 and act as leg assemblies. Elastic thread is given as an example of a material for the linear elastic members. The fixation section 10 is an elongated rectangular adhesive strip attached along the longitudinal direction L to the side of the outer thin layer 9 opposite the back thin layer 3. In the current model, six fixation sections 10 are available arranged in the transverse direction W.The 10 fixation sections fix the Light Incontinence Pad 1 to the thin wrapping layer (not shown) via a spacer when the Light Incontinence Pad 1 is individually wrapped, and reattach the Light Incontinence Pad 1 to the wearer’s underwear when using the Light Incontinence Pad 1. The base weights of the thin top layer 2, thin back layer 3, and absorbent body 4 are appropriately adjusted according to the required absorbency performance of the lightweight incontinence pad 1, but are not specifically limited as long as the components can be used as thin layers for the lightweight incontinence pad 1. Examples of base weights for the thin top layer 2 include 5 to 200 g / m². Examples of base weights for the thin back layer 3 include 5 to 200 g / m². Examples of base weights for the absorbent body 4 include 10 to 2000 g / m². The Light Incontinence Pad 1 contains an antibacterial liquid that includes an antibacterial agent and an organic solvent. The antibacterial liquid is present in a large quantity that covers the superabsorbent polymer located in the central section in the W-direction of the absorbent body 4. A smaller quantity of antibacterial liquid (ideally, zero coverage) covers the superabsorbent polymer located on the outer sides of the central section in the W-direction of the absorbent body 4. In other words, with respect to the W-direction, the antibacterial liquid only covers the superabsorbent polymer generally located in the central section in the W-direction, among the superabsorbent polymers in the absorbent body 4, and does not cover the sections on the outer sides to a significant extent. It is sufficient that at least a portion of the antibacterial liquid is present in the absorbent body 4 and that at least a portion of the antibacterial liquid in the absorbent body 4 covers a predetermined superabsorbent polymer. Specifically, it is not necessary for the antibacterial agent to completely cover the superabsorbent polymer. Examples of the central section in the transverse direction W of absorbent body 4, from the entire surface of absorbent body 4 in horizontal projection, include: if absorbent body 4 is divided into three transverse sectors W, the central section (one sector) excluding the two terminal sections (one sector each); if absorbent body 4 is divided into four transverse sectors W, the central sections (two sectors) excluding the two terminal sections (one sector each); and if absorbent body 4 is divided into five transverse sectors W, the central sections (three or one sector) excluding the two terminal sections (one or two sectors each, respectively). The sector boundaries may be slightly offset (approximately ±20%). The antibacterial liquid may be present in a greater quantity covering the superabsorbent polymer placed in the central section in the longitudinal direction L of the absorbent body 4, and may be present in a lesser quantity (preferably, the coverage should be zero (no coverage)) covering the superabsorbent polymer placed on the outer sides of the central section in the longitudinal direction L of the absorbent body 4. In other words, the antibacterial liquid may only cover the superabsorbent polymer generally placed in the central section in the longitudinal direction L, among the superabsorbent polymers in the absorbent body 4, and not cover the sections on the outer sides to a large extent.Examples of the central section in the longitudinal direction L of the absorbent body 4, from the whole surface of the absorbent body 4 in the horizontal projection, include, in the case of dividing the absorbent body 4 into three sectors in the longitudinal direction L, the central section (one sector) excluding the two terminal sections (one sector each); in the case of dividing the absorbent body 4 into four sectors in the longitudinal direction L, the central sections (two sectors) excluding the two terminal sections (one sector each); and in the case of dividing the absorbent body 4 into five sectors in the longitudinal direction L, the central sections (three or one sector) excluding the two terminal sections (one or two sectors each, respectively); the above sections are deflected by 10 to 30% forward in the longitudinal direction L. The sector boundaries may be deflected slightly (by approximately ±20%). As illustrated in Figure 1, in the current model, in the absorbent body 4 of the mild incontinence pad 1, the central section in the longitudinal direction L and the central section in the transverse direction W are referred to, in the horizontal projection, as the center region TA (these definitions are similarly used for the thin upper layer 2 and the thin posterior layer 3, which overlap with the absorbent body 4 in the thickness direction T). The center region TA, in the horizontal projection, is a section that includes the area of ​​contact with the outlet, and the antibacterial fluid is located at least in the center region TA. In the current model, the center region TA, in the horizontal projection, consists of the central sections (two segments) when the absorbent body 4 is divided into four equal segments in the longitudinal direction L and the central section (one segment) when the absorbent body 4 is divided into three equal segments in the transverse direction W. No specific method has been defined for coating the superabsorbent polymer with an antibacterial liquid, and any method may be used. For example, (a) a method in which the antibacterial liquid is applied by spray device to the superabsorbent polymer before the formation of the absorbent body. In this case, by placing the superabsorbent polymer coated with the antibacterial liquid in a predefined area of ​​the absorbent body, an absorbent body can be formed that includes the superabsorbent polymer coated with the antibacterial liquid in a predefined area. Alternatively, (b) a method is considered in which the superabsorbent polymer is placed on a thin core wrap layer, and the antibacterial liquid is applied by spray device from above onto the superabsorbent polymer within a predefined area of ​​the superabsorbent polymer. In this case, by wrapping the superabsorbent polymer coated with the antibacterial liquid along with the thin core wrap layer, an absorbent body may be formed that includes the superabsorbent polymer coated with the antibacterial liquid in a predefined area.Alternatively, (c) a method is considered in which an absorbent body is formed, comprising a superabsorbent polymer wrapped in a thin core film, and an antibacterial liquid is applied by a spray device to a predefined area of ​​the absorbent body's thin core film. In this case, as the antibacterial liquid migrates from the thin core film to the superabsorbent polymer, an absorbent body can be formed, comprising the superabsorbent polymer to which the antibacterial liquid has been applied, within a predefined area. Alternatively, (d) a method is considered in which a thin top film and an absorbent body are layered on top of each other, and an antibacterial liquid is applied by a spray device to a predefined area of ​​the thin top film of the multilayered body. In this case, as the antibacterial liquid migrates from the thin top film to the superabsorbent polymer within the absorbent body, an absorbent body may be formed, comprising the superabsorbent polymer to which the antibacterial liquid has been applied, within a predefined area. The definition of an antibacterial agent is not specifically defined as long as the agent can be used in hygiene products. In the current model, an antibacterial agent includes hydrophilic antibacterial agents. A hydrophilic antibacterial agent is one that dissolves in 40 g or more of 100 g of water at 25°C within 5 hours. It is sufficient for an antibacterial agent to possess both hydrophilicity and an antibacterial function, i.e., the ability to inhibit bacterial growth, which is not specifically defined. Examples of antibacterial agents include cationic antibacterial agents. Examples of cationic antibacterial agents include guanidine antibacterial agents, biguanide antibacterial agents, and quaternary ammonium salts. An example of a guanidine antibacterial agent is polyhexamethylene guanidine (PHMG).Examples of biguanide antibacterial agents include polyhexamethylene biguanide (PHMB), also known as polyaminopropyl biguanide. Examples of quaternary ammonium salts include benzalkonium chloride and benzethonium chloride. These antibacterial agents can be used individually or in combination. The organic solvent is not specifically defined as long as it can be used in hygiene products and acts as a solvent for an antibacterial agent. In the current model, the organic solvent includes organic solvents that are preferably hydrophilic and, even more preferably, non-volatile. In other words, the solvent in the formulation includes a hydrophilic, non-volatile organic solvent. A hydrophilic organic solvent refers to an organic solvent that is miscible with water in any proportion. A non-volatile organic solvent refers to an organic solvent with a vapor pressure of 50 Pa or less at 25°C. Examples of organic solvents include glycols and alcohols. Examples of glycols include propylene glycol (PG), dipropylene glycol (DPG), 1,3-butylene glycol (BG), and polyethylene glycol 400 (PEG 400). Examples of alcohols include 3-methoxy-3-methyl-1-butanol. These organic solvents can be used individually or in combination. The minimum total ratio of antibacterial agent to organic solvent in the antibacterial solution, from the perspective of ensuring antibacterial activity, should be, for example, 90% by mass, preferably 95% by mass or more. The antibacterial solution may also contain an additional solvent, such as water, in addition to the antibacterial agent and organic solvent. To prevent evaporation of the antibacterial solution and corrosion of the manufacturing equipment, the water content should ideally be less than the organic solvent. The minimum total ratio of antibacterial agent to total antibacterial agent and solvent (organic solvent + additional solvent), from the perspective of ensuring antibacterial activity, should be, for example, 1% by mass, preferably 2% by mass or more. The maximum ratio, from the perspective of the solubility of the antibacterial agent in the solvent, should be, for example, 60% by mass, preferably 50% by mass or more.The solvent of the antibacterial liquid can be identified and quantified using GC / MS (gas chromatography mass spectrometry), and the antibacterial agent in the formulation can be identified and quantified using LC / MS (high-performance liquid chromatography mass spectrometry). In the mild incontinence pad 1, there is a greater amount of antibacterial fluid covering the superabsorbent polymer placed in the central section in the transverse direction W of the absorbent body 4, and a lesser amount (preferably zero coverage (no coverage)) covering the superabsorbent polymer placed on the outer sides of the central section in the transverse direction W of the absorbent body 4. Consequently, the body fluid in the central section in the transverse direction W of the absorbent body 4 comes into contact with the antibacterial fluid covering the superabsorbent polymer, allowing the antibacterial agent in the antibacterial fluid to exhibit its antibacterial properties. Because the superabsorbent polymer in the central section (W-direction) of the absorbent body 4 is coated with an antibacterial solution, the absorption rate of body fluid by the superabsorbent polymer in the central section (W-direction) is reduced. This prevents the body fluid from being absorbed by the superabsorbent polymer in the central section (W-direction) and allows the body fluid to easily diffuse to both outer sides (W-direction) of the central section. In particular, the diffusion of body fluid to the outer sides (W-direction) is improved. Subsequently, the diffused body fluid can be easily absorbed by the superabsorbent polymer applied to both outer sides (W-direction) of the central section, which is minimally coated with the antibacterial solution. Consequently, the absorbent body 4 can be used over a wide area, and lateral leakage, where body fluid leaks from the peripheral sections (W-direction) of the mild incontinence pad 1, can be prevented. In the mild incontinence pad 1, which includes an antibacterial liquid and a super-absorbent polymer, both antibacterial and absorbent performance can be achieved. When the antibacterial liquid further covers the superabsorbent polymer placed in the central section in the longitudinal direction L of the absorbent body 4 and does not cover the superabsorbent polymer placed on both outer sides of the central section in the longitudinal direction L, the same effect can be obtained in the longitudinal direction L as is obtained in the transverse direction W, which is obtained when the antibacterial liquid covers the superabsorbent polymer placed in the central section in the transverse direction W and does not cover the superabsorbent polymer placed on both outer sides of the central section in the transverse direction W. One of the advantages of the current model is that the absorbent body 4 has a bilayer structure. The bilayer structure of the absorbent body 4 will be described in detail below. Figures 3 and 4 are horizontal projections illustrating schematic examples of an upper layer 11 absorbent and an lower layer 12 absorbent, respectively, in a mild incontinence pad 1, according to the models. As shown in Figures 2 through 4, the mild incontinence pad 1 also includes, like absorbent 4, an upper layer 11 absorbent and a lower layer 12 absorbent placed on the side furthest from the skin in the T-thickness direction relative to the upper layer 11 absorbent. In the current model, the top layer 11 absorbent body is a thin-film-like absorbent layer with the ability to absorb and retain fluids. It has an approximately elongated rectangular shape in the longitudinal direction (L) in the horizontal projection. The top layer 11 absorbent body is positioned on the side of the top layer 2. The top layer 11 absorbent body consists of an absorbent core 11a containing a superabsorbent polymer; a skin-side 11b1 thin-film wrapping layer for the core; and a skin-side 11b2 thin-film wrapping layer for the core, which enclose (overlap) the absorbent core 11a. The absorbent core material 11a is not specifically defined as long as the superabsorbent polymer described above is included, and may include, for example, pulp fibers in addition to the superabsorbent polymer. The pulp fiber content is in the range of 0 to 90% by mass of the superabsorbent polymer. In the current model, the amount of superabsorbent polymer in the top-layer absorbent body 11 is greater than the amount of superabsorbent polymer in the bottom-layer absorbent body 12. In the current model, the absorbent core 11a consists solely of superabsorbent polymer. This absorbent body, which includes an absorbent core with a superabsorbent polymer content of 90% by mass or greater, is also referred to as a superabsorbent polymer thin film. The specific materials for the skin-side thin core wrap (11b1) and the dissimilar skin-side thin core wrap (11b2) are not defined, provided that these thin wraps are permeable to liquids. Examples include permeable nonwoven fabrics (such as tissue paper) made from synthetic resin fibers or pulp fibers. Permeable nonwoven fabrics are as described above. Examples of basic weights for the skin-side thin core wrap (11b1) and the dissimilar skin-side thin core wrap (11b2) range from 5 to 100 g / m². The superabsorbent polymer (and pulp fibers) in absorbent pulp 11a is best fixed to at least one of the skin-side thin-wrap 11b1 and skin-side thin-wrap 11b2 layers with a heat-melting adhesive (not shown). However, the superabsorbent polymer can simply be wound onto the skin-side thin-wrap 11b1 and skin-side thin-wrap 11b2 layers without fixing. Typical base weights for absorbent pulp 11a range from 50 to 400 g / m². In the current model, the absorbent core in the bottom layer 12 is an absorbent layer with both liquid absorption and liquid retention performance. It is approximately rectangular in shape, longitudinally L-shaped in the horizontal projection, with its longitudinal L-shaped edges forming a circular arc and the middle section narrowing in the longitudinal L-shaped to the transverse W-shaped. The absorbent core in the bottom layer 12 is positioned on the side of the thin backing layer 3. The absorbent core in the bottom layer 12 consists of an absorbent core 12a, which includes a superabsorbent polymer and pulp fibers; a thin core wrapping layer 12b1 adjacent to the skin; and a thin core wrapping layer 12b2 distant from the skin, with the absorbent core 12a enclosed (interlocked) between them. The specific materials for the absorbent core 12a are not defined, provided they include the core fibers and / or superabsorbent polymer described above. The superabsorbent polymer content ranges from 0 to 90% by mass of the core fibers. In the current model, the amount of core fibers in the bottom layer 12 absorbent body is greater than the amount in the top layer 11 absorbent body. In the current model, the absorbent core 12a has a superabsorbent polymer content of 30% by mass of the core fibers. The materials for the 12B1 skin-side thin core wrap and the 12B2 skin-side thin core wrap are the same as those used for the 11B1 skin-side thin core wrap and the 11B2 skin-side thin core wrap for the absorbent body in the top layer 11. Examples of basic weights for the 12B1 skin-side thin core wrap and the 12B2 skin-side thin core wrap include 5 to 100 g / m2. The superabsorbent polymer and core fibers are best fixed in absorbent core 12a with at least one skin-side wrap 12b1 and one away-side wrap 12b2 using a heat-melting adhesive (not shown). However, the superabsorbent polymer and core fibers can simply be wrapped with a skin-side wrap 12b1 and one away-side wrap 12b2 without fixing. Examples of base weights for superabsorbent polymers range from 0 to 600 g / m². Base weights for core fibers range from 50 to 700 g / m². The absorbent material is bonded to the top layer 11 and the top thin layer 2 by an adhesive agent. The absorbent material is bonded to the top layer 11 and the bottom layer 12 by an adhesive agent. The absorbent material is bonded to the bottom layer 12 and the back thin layer 3 by an adhesive agent. Examples of adhesive agents include heat-melting adhesives. In a preferred aspect of the current model, as described above, the mild incontinence pad 1 includes an absorbent core in the top layer 11 and an absorbent core in the bottom layer 12. In this case, at least in the absorbent core in the top layer 11, the antibacterial fluid is present in a greater quantity than the superabsorbent polymer placed in the central section in the transverse W direction. Furthermore, the antibacterial fluid is present in a smaller quantity (preferably zero coverage) than the superabsorbent polymer placed on both outer sides of the central section in the transverse W direction. In other words, the antibacterial fluid only covers the superabsorbent polymer generally placed in the central section in the transverse W direction, within the superabsorbent polymers of the absorbent core in the top layer 11, and does not significantly cover the sections on the outer sides. The central section is in the transverse W direction as described above.In the top-layer absorbent body 11, the method of coating the superabsorbent polymer with the antibacterial liquid is as described in the methods (a) to (d) for coating the superabsorbent polymer with the antibacterial liquid described above. In the absorbent body with at least the top layer 11, the antibacterial fluid may be present in a greater quantity covering the superabsorbent polymer located in the central section in the longitudinal L direction. Additionally, the antibacterial fluid may be present in a smaller quantity covering the superabsorbent polymer located on the outer sides of the central section in the longitudinal L direction. In other words, the antibacterial fluid may only cover the superabsorbent polymer generally located in the central section in the longitudinal L direction, among the superabsorbent polymers in the absorbent body with the top layer 11, and may not cover the sections on the outer sides to a significant extent. The central section is in the longitudinal L direction as described above. In the top-layer absorbent body 11, the superabsorbent polymer in the central section (W-direction) is coated with an antibacterial fluid. Consequently, as the body fluid passes through the top-layer absorbent body 11, it comes into contact with the antibacterial fluid coating the superabsorbent polymer, allowing the antibacterial agent in the antibacterial fluid to exert its antibacterial properties. Because the superabsorbent polymer in the central section of the absorbent body (top layer 11) is coated with an antibacterial liquid, the absorption of the body fluid by the superabsorbent polymer in the central section can be prevented. Consequently, the body fluid may readily migrate to the absorbent body (bottom layer 12). In this case, as the body fluid migrates to the absorbent body (bottom layer 12), the antibacterial liquid gradually migrates to the absorbent body (bottom layer 12), and thus, the amount of antibacterial liquid in the absorbent body (bottom layer 12) may increase. In particular, the antibacterial properties of the absorbent body (bottom layer 12) increase depending on the amount of body fluid. Not only during the initial absorption of body fluid, but also during subsequent absorption processes, the absorption of body fluid is prevented by the superabsorbent polymer in the central section of the absorbent body with the top layer 11. Thus, the rewetting capability of the mild incontinence pad can be improved 1. In the top-layer absorbent body (11), the superabsorbent polymer on both outer sides of the central section in the transverse W direction, which is minimally coated with antibacterial fluid, generally maintains its original absorption performance at both end sections in the transverse W direction. Therefore, the body fluid can be absorbed into the superabsorbent polymer at both end sections in the transverse W direction, further preventing lateral leakage of the body fluid. If the antibacterial liquid is found in a larger quantity covering the superabsorbent polymer placed in the central section in the longitudinal direction L of the absorbent body in the top layer 11, and is found in a smaller quantity covering the superabsorbent polymer placed on both outer sides of the central section in the longitudinal direction L, then in the longitudinal direction L the same effect can be obtained as in the transverse direction W, which is obtained when the antibacterial liquid is found in a larger quantity covering the superabsorbent polymer placed in the central section in the transverse direction W and is found in a smaller quantity covering the superabsorbent polymer placed on both outer sides of the central section in the transverse direction W. In a preferred aspect of the current model, a portion of the antibacterial fluid is contained in the absorbent body of the lower layer 12. The amount of antibacterial fluid in the absorbent body of the upper layer 11 is greater than the amount of antibacterial fluid in the absorbent body of the lower layer 12. The amount of antibacterial fluid in the absorbent body of the lower layer 12 may be 0 (zero). The antibacterial liquid contained in the absorbent body in the lower layer 12 can be placed on the absorbent body in the lower layer 12, or it can be transferred from the absorbent body in the upper layer 11. The method for applying the antibacterial liquid to the bottom-layer absorbent is not specifically defined, and any method may be used. For example, when the bottom-layer absorbent material includes pulp fibers and / or a superabsorbent polymer, in methods (a) to (c) for coating the superabsorbent polymer with the antibacterial liquid described above, methods in which the superabsorbent polymer is replaced by pulp fibers and / or a superabsorbent polymer are considered. Alternatively, (e) consider a method in which the top-layer absorbent and bottom-layer absorbent are layered together, and the antibacterial liquid is applied to a predefined area of ​​the top-layer absorbent of the multilayered object, or in which the top-layer absorbent, to which the antibacterial liquid has been applied, is layered onto a bottom-layer absorbent.In this case, as the antibacterial fluid moves from the upper layer absorbent body to the pulp fibers and / or superabsorbent polymer in the lower layer absorbent body, a lower layer absorbent body may be formed that includes pulp fibers and / or superabsorbent polymer onto which the antibacterial fluid has been applied in a predefined area. In the mild incontinence pad 1, there is a portion of antibacterial fluid in the absorbent body in the lower layer 12, and the amount of antibacterial fluid in the absorbent body in the upper layer 11 is greater than the amount of antibacterial fluid in the absorbent body in the lower layer 12. Due to the presence of antibacterial fluid, although in a small amount, in the absorbent body in the lower layer 12, the antibacterial properties can be shown to appear efficiently from the first absorption of the body fluid. In one of the advantages of the current model, the bottom layer 12 absorbent body contains at least two core fibers, unlike the top layer 11 absorbent body. The bottom layer 12 absorbent body contains a greater quantity of core fibers than the top layer 11 absorbent body. Accordingly, the top layer 11 absorbent body contains fewer core fibers, which readily retain body fluid around the antibacterial agent (superabsorbent polymer). Consequently, the antibacterial effect of the antibacterial agent may be prolonged in the top layer 11 absorbent body. The bottom layer 12 absorbent body contains more core fibers, thus allowing for rapid absorption and easy retention of body fluid. In this case, the body fluid may be retained by the bottom layer 12 absorbent body, effectively separating it from the body, thereby preventing skin irritation. With reference to Figure 2, Figure 3, and Figure 4, the top-layer absorbent body 11 and the bottom-layer absorbent body 12 will be described in further detail. In the top-layer absorbent body 11, as shown in Figure 3, the regions formed between the skin-side thin core wrap 11b1 and the distal thin core wrap 11b2 are divided into a variety of PEA placement zones (21, 22) in the horizontal projection by a number of NPA bonding zones (31, 32, 32'). Each NPA bonding zone is formed by bonding a section of the skin-side thin core wrap 11b1 and, opposite it, a section of the distal thin core wrap 11b2 together in the thickness direction T by compression (e.g., embossing) or by compression using an adhesive agent (e.g., a heat-melting adhesive). Each PEA placement zone consists of a zone formed by a section of the thin core wrapping layer adjacent to the skin 11b1 and, opposite it, one section of the thin core wrapping layer away from the skin 11b2. In each PEA placement zone, an absorbent material is placed (at least a superabsorbent polymer, among superabsorbent polymers and core fibers).Therefore, each of the PEA placement regions (21, 22) can be referred to as a superabsorbent polymer region, where superabsorbent polymer is present. Each of the NPA binding regions (31, 32, 32') can be referred to as a superabsorbent polymer region, where superabsorbent polymer is absent. In the current model, the absorbent body in the top layer 11 is divided into three PEA positioning zones in the transverse W direction by a pair of NPA binding zones. These three PEA positioning zones are then sealed anteriorly and posteriorly in the longitudinal L direction by additional NPA binding zones. The three PEA positioning zones consist of a 21 positioning zone located in the central section in the transverse W direction and extending longitudinally L; and a pair of 22 positioning zones located at the two end sections in the transverse W direction and extending longitudinally L. The pair of NPA binding zones consists of 31 band-shaped binding zones extending longitudinally L and arranged at a predetermined interval on both sides in the transverse W direction, with a center line between them longitudinally. The additional NPA binding zones consist of 32 (anterior side) and 32' (posterior side) band-shaped binding zones extending transversely W and arranged at a predetermined interval on both sides in the longitudinal L direction, with a center line between them transversely.The 31 pair of connection zones pattern consists of a pattern that forms strip-like shapes such that the gap between them is narrow near the center in the longitudinal direction L and widens towards both outer sides in the longitudinal direction L. The 31 pair of connection zones pattern is formed along the length of the compressed section pair pattern 5 described below and is formed wider. In the current model, Position 21 and Position 22 consist of the 11b1 skin-side thin core wrap layer and the 11b2 skin-side thin core wrap layer, the 31 duck-pair pair, and the 32' (front side) and 32' (back side) additional bonding zones. Position 21 is longitudinally L-shaped and hourglass-shaped, with its central section narrowing longitudinally L to transversely W-shaped. Position 22 is roughly rectangular in shape, longitudinally L-shaped, with one side extending inwards transversely W in a curved line directed towards the longitudinal centerline. In the current model, the 31 bonding pair, the 32' (front side) additional bonding zone, and the 32' (back side) additional bonding zone are composed of high-density sections with a higher fiber density than the surroundings, achieved through compression. The shapes of the pair of binding zones 31 and the additional binding zones 32 (front side) and 32' (back side), i.e., the shapes of position zone 21 and the pair of position zones 22, are arbitrary. In the case of the current model, the superabsorbent polymer placed in the central section in the transverse direction W can form a superabsorbent polymer placed in position 21, and the superabsorbent polymer placed on both outer sides of the central section in the transverse direction W can form a superabsorbent polymer placed in the pair of position 22 regions. In this case, there is a greater amount of antibacterial liquid covering the superabsorbent polymer placed in position 21, and a lesser amount (preferably, zero coverage) covering the superabsorbent polymer placed in the pair of position 22 regions. Body fluid is secreted near position 21 and comes into contact with an antibacterial solution coating the superabsorbent polymer. This allows the antibacterial agent in the antibacterial solution to exhibit its antibacterial properties. Furthermore, because the superabsorbent polymer in position 21 is coated with the antibacterial solution, the absorption rate of body fluid by the superabsorbent polymer in position 21 is reduced. This prevents the superabsorbent polymer from absorbing the body fluid and allows the body fluid to easily diffuse to both outer sides in the transverse W direction of the central section. In particular, the diffusion of body fluid to both outer sides in the transverse W direction is enhanced. Subsequently, the diffused body fluid can be easily absorbed by the superabsorbent polymer placed in a pair of position 22 areas, which are minimally coated with the antibacterial solution. Consequently, the absorbent material with the top layer 11 can be used over a wide area, and lateral leakage, where body fluid leaks from the peripheral sections in the transverse W direction of the mild incontinence pad 1, can be prevented. In the current model, the absorbent body in the bottom layer 12, as shown in Figure 4, has a space between the thin core wrapping layer next to the skin 12b1 and the thin core wrapping layer away from the skin 12b2 filled with superabsorbent polymer and core fibers 12a. The absorbent body in the bottom layer 12 includes a high-thickness region 12m that is approximately rectangular in shape with rounded corners at the center in the transverse direction W and the longitudinal direction L, a medium-thickness region that is approximately ring-shaped surrounding the perimeter of the high-thickness region 12m, and a low-thickness region with an outer shape of the absorbent body in the bottom layer 12 that is largely ring-shaped surrounding the perimeter of the medium-thickness region. The thickness of the high-thickness region (12m) is highest in the direction of thickness T, the thickness of the low-thickness region is lowest in the direction of thickness T, and the thickness of the medium-thickness region in the direction of thickness T is intermediate between the thickness of the low-thickness region and the high-thickness region (12m). Therefore, the absorbent body in the lower layer (12m) has a central mass structure (e.g., a large mass in the center).In the current model, in the horizontal projection, the high-thickness area of ​​12m is generally an area corresponding to the central area TA. In the current model, the mild incontinence pad 1 comprises a pair of 5-piece compression sections extending longitudinally (L) and spaced with a predefined gap in transversely (W). Each 5-piece compression section is formed by compressing (e.g., embossing) the top layer 2, the absorbent body of the top layer 11, and the absorbent body of the bottom layer 12 in the thickness direction (T). Each 5-piece compression section extends from the top thin layer 2 into the absorbent body of the top layer 11 and into the absorbent body of the bottom layer 12. In the lower (distant from the skin side) section of each 5-piece compression section, a high-density section with a higher fiber density compared to the surrounding compression is formed. The 5-piece compression sections may reach the skin side surface of the back thin layer 3 from the surface of the top thin layer 2 in the thickness direction (T). The width of the 5-piece compression sections includes, for example, 1 to 5 mm. There is no specific pattern for a pair of compressed sections 5 in particular, and any known pattern used in absorbent tools can be adopted.The current model includes a pattern in which the distance between the pair of compressed sections 5 decreases (narrows) near the center in the longitudinal direction L, increases (widens) towards the outer sides in the longitudinal direction L, and decreases (narrows) again when approaching each of the two terminal sections of the absorbent body in the lower layer 12. This pattern facilitates the diffusion of what has been secreted, which travels in the longitudinal direction L along the pair of compressed sections 5 in both the transverse direction W and the longitudinal direction L. In the current model, the mild incontinence pad 1 includes additional 6 compressed sections on the anterior and posterior sides in the longitudinal direction L, extending in the transverse direction W and arranged at a predetermined distance in the longitudinal direction L. The structure of the 6 compressed sections is similar to that of the 5 compressed sections. The 6 compressed sections are placed between the pair of 5 compressed sections near both terminal sections in the longitudinal direction L of the pair of 5 compressed sections, in the form of circular arcs protruding outwards. In the mild incontinence pad 1, the upper absorbent body 11, in horizontal projection, contains areas of superabsorbent polymer (PEA), i.e., the PEA placement zones (21, 22), and areas free of superabsorbent polymer (NPA), i.e., the NPA binding zones (31, 32, 32'). Each NPA-free zone (NPA binding zone) contains a compact section 5. Therefore, additional body fluid can be transferred from the upper absorbent body 11 to the lower absorbent body 12 via the compact sections 5 without being impeded by the superabsorbent polymer in the PEA placement zones (21, 22). This enhances the fluid transfer properties from the upper absorbent body 11 to the lower absorbent body 12, potentially further preventing lateral leakage of body fluid. In one of the advantages of the current model, a greater quantity of antibacterial fluid covers the superabsorbent polymer located in the central section in the longitudinal direction (L) than the absorbent body in the top layer 11 (absorbent body 4). The quantity of antibacterial fluid covering the superabsorbent polymer located in the anterior (ventral) section relative to the central section in the longitudinal direction (L) of the absorbent body in the top layer 11 (absorbent body 4) is less. In other words, in the longitudinal direction (L), the antibacterial fluid only covers the superabsorbent polymer generally located in the central section or in the central section and the posterior (dorsal) side, among the superabsorbent polymers in the absorbent body in the top layer 11 (absorbent body 4), and does not cover the sections on the outer sides to a significant extent. It is sufficient for at least a portion of the antibacterial fluid in the absorbent body in the top layer 11 to cover at least a portion of the antibacterial fluid present in the absorbent body in the top layer 11 to cover a predetermined superabsorbent polymer.Specifically, the antibacterial agent does not need to completely cover the superabsorbent polymer. In the mild incontinence pad 1, the antibacterial fluid is present in a greater quantity covering the superabsorbent polymer placed in the central section in the longitudinal L direction of the absorbent core in the top layer 11 (absorbent core 4), and in a lesser quantity (ideally, 0% coverage) covering the superabsorbent polymer placed in the anterior (ventral) section relative to the central section in the longitudinal L direction of the absorbent core in the top layer 11 (absorbent core 4). Accordingly, the absorption of body fluid by the superabsorbent polymer in the central section in the longitudinal L direction is prevented, while the body fluid is readily absorbed by the superabsorbent polymer on the ventral side relative to the central section in the longitudinal L direction, which is minimally covered by the antibacterial fluid and therefore has a relatively high absorption rate. In the ventral section (anterior lateral section in the longitudinal direction) of the body that the upper layer 11 absorbent body (absorbent body 4) is likely to come into direct or indirect contact with, the antibacterial fluid is absent from the upper layer 11 absorbent body (absorbent body 4). Therefore, contact between the antibacterial fluid and the body can be prevented, thus preventing skin irritation by the antibacterial agent present in the antibacterial fluid. In a preferred aspect of the current model, the top-layer absorbent body 11 includes a paradermal section 51 positioned on the skin side in the thickness T direction and a distal section 52 positioned on the side farther from the skin than the paradermal section in the thickness T direction. The water retention rate of the paradermal section 51 is lower than the water retention rate of the distal section 52. Examples of methods to reduce the water retention rate in the skin-side section 51 of the top-layer absorbent body 11 include applying an antibacterial fluid via a spray device from the skin-side onto the top-layer absorbent body 11. Alternatively, other examples include applying an antibacterial fluid from the side of the thin top layer 2 onto the multilayered thin top layer 2 and absorbent body 4 to transfer the antibacterial fluid to the skin-side from the top-layer absorbent body 11 via the thin top layer 2. Accordingly, more antibacterial fluid is applied to the superabsorbent polymer in the skin-side section 51 compared to the distal section 52, and the water retention rate of the superabsorbent polymer in the skin-side section 51 is reduced. In mild urinary incontinence pad 1, the water retention rate of the 51st skin-side portion of the top layer absorbent material 11 is relatively low. Therefore, the 51st skin-side portion, which is the upper surface of the top layer absorbent material 11, can be conveniently kept dry (smooth). The water retention rate of the 52nd skin-side portion of the top layer absorbent material 11 is relatively high. Consequently, the superabsorbent polymer coated with an antibacterial agent can make sufficient contact with body fluid on the 52nd skin-side portion, which is the posterior surface of the top layer absorbent material 11, potentially enhancing the antibacterial performance of the antibacterial agent. In one preferred aspect of the current model, the skin-side thin pulp wrapping layer 12b1 and the distal skin-side thin pulp wrapping layer 12b2 of the absorbent body are made of crinkled paper. The crinkled paper is a non-woven fabric (including paper) that has undergone a crinkling process. It consists of synthetic resin fibers or pulp fibers and has an uneven structure with recessed and raised sections that form a variety of creases. The degree of unevenness of the skin-side thin pulp wrapping layer 12b1 is less than that of the distal skin-side thin pulp wrapping layer 12b2. The degree of unevenness refers to the number of unevennesses (creases) per unit length in a direction (e.g., transverse direction W) perpendicular to the direction (e.g., longitudinal direction L) in which the unevenness (creases) extends, and / or the magnitude of the unevenness (creases). The magnitude of the unevennesses refers to the height of the unevennesses and / or the width of the unevennesses. The elevation of unevenness refers to the elevation from the bottom of a recessed section (the section between adjacent elevated sections) to the top of an elevated section.The width of the unevenness refers to the distance between the crests of adjacent raised sections or the troughs of adjacent sunken sections. A small degree of unevenness indicates a few unevennesses, low height of unevennesses, and / or a large width of unevennesses, excluding the absence of unevenness, in order to maintain a certain level of deformability on the skin side of the absorbent body. The degree of unevenness in creased paper can be adjusted depending on the creasing process and the application of a liquid to the paper. For example, when a liquid (e.g., an antibacterial solution) is applied to the creased paper, the applied section becomes saturated and softened, making it easier to smooth out the uneven area and thus reducing the degree of unevenness. In this case, to easily maintain affinity with the body's fluid and the degree of unevenness, it is preferable to use a hydrophilic, non-volatile liquid when applying the liquid to the creased paper. In the current model, there is no need for the degree of unevenness over the entire surface of the 12b1 skin-side thin core wrap to be less than that over the 12b2 skin-side thin core wrap. Examples of sections with a slight degree of unevenness over the entire surface of the 12b1 skin-side thin core wrap in the horizontal projection include, if the 12b1 skin-side thin core wrap is divided into three sections in the transverse direction W, the central section (one section) excluding the two terminal sections (one section each); if the 12b1 skin-side thin core wrap is divided into four sections in the transverse direction W, the central sections (two sections) excluding the two terminal sections (one section each). In the case of dividing the thin core wrap layer next to the skin 12b1 into five sections in the transverse direction W, the central sections (three or one section) excluding both terminal sections (one or two sections each, respectively), and / or examples of sections with a small degree of unevenness described above, the entire surface of the thin core wrap layer next to the skin 12b1 in the horizontal projection, for example,If the 12B1 skin-side thin pulp wrap is divided into three longitudinal L-directions, the central section (one section) is excluded from both terminal sections (one section each); if the 12B1 skin-side thin pulp wrap is divided into four longitudinal L-directions, the central sections (two sections) are excluded from both terminal sections (one section each); and if the 12B1 skin-side thin pulp wrap is divided into five longitudinal L-directions, the central sections (three or one section) are excluded from both terminal sections (one or two sections each, respectively). The above sections are deflected 10 to 30% forward in the longitudinal L-direction. The section boundaries may be slightly deflected (approximately ±20%). In all the cases described above, the section with the lowest degree of unevenness, in the horizontal projection, should ideally include the area of ​​contact with the outlet orifice and preferably an area overlapping with the 12A absorbent core. In the current model, the 12B1 skin-side thin-walled pulp wrapping layer and the 12B2 skin-side thin-walled pulp wrapping layer surround the 12A absorbent pulp, such that the unevenness and wrinkles of the crumpled paper extend along the longitudinal direction L. However, it is not necessary for both the 12B1 skin-side thin-walled pulp wrapping layer and the 12B2 skin-side thin-walled pulp wrapping layer to have unevenness and wrinkles across their entire surface. Of the total surface area of ​​both the 12B1 skin-side thin-walled pulp wrapping layer and the 12B2 skin-side thin-walled pulp wrapping layer, it is sufficient for the unevenness and wrinkles to constitute an area of ​​90% or more, preferably an area of ​​95% or more, and ideally an area of ​​98% or more, which includes the contact area with the outlet port. Accordingly, tearing caused by an external force in both the 12B1 skin-side thin-walled pulp wrapping layer and the 12B2 skin-side thin-walled pulp wrapping layer can be easily reduced. In the current model, in the epidermal side of the thin core wrapping layer 12b1, the number (average) of unevennesses (wrinkles) extending along the longitudinal direction L per unit length in centimeters in the transverse direction W is, for example, 1 to 50. In the epidermal side of the thin core wrapping layer 12b1, the height (average) of unevennesses (wrinkles) is, for example, 0.1 to 1 mm. In the distal side of the thin core wrapping layer 12b2, the number (average) of unevennesses (wrinkles) extending along the longitudinal direction L per unit length in centimeters in the transverse direction W is, for example, 2 to 100. In the distal side of the thin core wrapping layer 12b2, the height (average) of unevennesses (wrinkles) is, for example, 0.2 to 2 mm. The unevenness width includes (average) unevenness, the size of which is, for example, 0.1 to 5 mm. In the mild incontinence pad 1, in the absorbent body of the lower layer 12, the degree of unevenness in the skin-side thin pulp wrapping layer 12b1, which is made of uneven crinkled paper, is relatively low, allowing for improved fluid diffusion in the flat direction of the skin-side thin pulp wrapping layer 12b1. At the same time, the contact area between the absorbent body in the top layer 11 and the skin-side thin pulp wrap layer 12B1 can be increased, and the contact area between the skin-side thin pulp wrap layer 12B1 and the absorbent core 12A can be increased. Accordingly, during use, the fluid secreted in the mild incontinence pad 1 may spread from the absorbent body in the top layer 11 to the skin-side thin pulp wrap layer 12B1 in the horizontal direction of the skin-side thin pulp wrap layer 12B1 and subsequently transfer to the absorbent core. Increasing the unevenness of the 12B2 distal paper core wrap, the 12B2 distal paper core wrap can easily become deformed. Even with the expansion and contraction of the mild incontinence pad 1 due to the wearer's body movements during use, the 12B2 distal paper core wrap may follow this expansion and contraction, potentially reducing tearing. In this case, because the unevenness of the 12B2 distal paper core wrap absorbs the external force resulting from body movements, the external force acting on the 12B1 skin-side core wrap may be reduced, thus reducing tearing of the 12B1 skin-side core wrap. In a preferred aspect of the current model, the thin top layer 2 includes an agent that increases water affinity, and the viscosity of the antibacterial liquid is higher than the viscosity of the water-affinity agent. The thin top layer 2, for example, is formed by treating the material that forms it with a hydrophilic agent known in the relevant technical field (e.g., applying a hydrophilic agent or kneading the hydrophilic agent into the material). The hydrophilic agent is not specifically defined as long as it can be used for absorbents; examples include alkyl phosphate ester salts and alkyl phosphate metal salts. Alternatively, examples of hydrophilic agents include a mixture of a 10- to 30-carbon alkyl phosphate ester salt and a betaine compound, a sulfate ester salt, or a phosphate ester salt, each with 10- to 30-carbon atoms; and a mixture of an alkyl phosphate ester salt and polyether-modified silicone. In the mild incontinence pad 1, the viscosity of the antibacterial fluid in the absorbent body 4 is higher than the viscosity of the water-affinity-enhancing agent in the thin top layer 2. Therefore, compared to the water-affinity-enhancing agent, which is easily flushed out by body fluid, the antibacterial fluid is easily flushed out by body fluid. Thus, even when body fluids are flushed out several times in the mild incontinence pad 1, the condition in which the antibacterial fluid covers the super-absorbent polymer can be easily maintained, and the sustainability of the antibacterial agent's effect can be increased. <Method for measuring the degree of unevenness of the thin core wrapping layer> The degree of unevenness of the thin core wrapping layer is measured as follows. (1) It is divided into three equal sections in both the transverse and longitudinal directions to prepare nine samples. (2) Each specimen is frozen using liquid nitrogen and cut in the direction of thickness with a sharp knife so that the cross-section can be examined where it is desired to measure the degree of unevenness of each specimen (e.g., the central section in the longitudinal and transverse directions, and the section from front to back in the longitudinal direction) in a cross-sectional manner, without affecting the degree of unevenness. The size of the cut may be 1 cm × 1 cm. (3) A microscope or optical microscope (e.g., VHX-7000 manufactured by Keyence) is prepared to capture cross-sectional images of each specimen at a magnification of 10 to 100 times. (4) In the photographs taken for each sample, the number of unevennesses (wrinkles) is measured for each unit length and / or height and / or width of unevenness for the recessed and raised sections. (5) The average of the measured values ​​for the nine samples is calculated (at least the three nearest samples if the variance due to location is large (±30% or greater)) to be used as the final number of unevenness (wrinkles) per unit length and / or final height and / or width of unevenness. <Method for measuring the application area of ​​antibacterial liquid (containing an antibacterial agent)> Regarding the method of measuring the quantity of antibacterial liquid (containing an antibacterial agent) in an area where the antibacterial liquid is applied, the quantity is measured as follows. (1) A section of a predetermined size (e.g., 1 cm x 1 cm) is cut, where it is desirable to check whether the antibacterial liquid has been applied or not, and is used as a sample. (2) The antibacterial agent in the sample is identified and its quantity is determined using (high-performance liquid chromatography mass spectrometry). (3) (1) and (2) above are performed on three samples, and the average of their values ​​is calculated to determine the presence and quantity of antibacterial fluid in the corresponding sections. (4) (1) to (3) above are performed on a variety of multiple sections of the absorbent instrument, and the areas to which the antibacterial liquid is applied and the quantities of antibacterial liquid in those areas are determined. A method for measuring the viscosity of an antibacterial liquid and the agent that increases water affinity. When measuring a sufficient quantity of an antibacterial liquid or water-affinity-enhancing agent, the viscosity of the antibacterial liquid or water-affinity-enhancing agent is measured as follows. (1) The following device is prepared: HAAKE RheoStress 1 (Sensor: 60 mm cone, 1° C60 / 1 angle) manufactured by Thermo Fisher Scientific. (2) 38 milliliters of antibacterial liquid or affinity-enhancing agent for the water to be measured are added to a container connected to the device, and a probe is immersed in the antibacterial liquid. (3) Viscosity is measured under the following conditions: Temperature 25°C, humidity 50%, shear rate: 10.0 (1 / second). <Method for measuring the water retention rate of superabsorbent polymer> One method for measuring the water retention rate of a superabsorbent polymer in the absorbent body with the top layer is as follows. (1) In the absorbent body of the top layer of the absorbent device, a thin core wrapping layer next to the skin to which the superabsorbent polymer is attached and a thin core wrapping layer away from the skin to which the superabsorbent polymer is attached are peeled away from each other to separate a skin-side section and a section away from the skin to the top layer of the absorbent body. (2) The other thin layers and adhesion factors associated with the thin pulp wrapping layer on the skin side are removed with an organic solvent that is not absorbed by the superabsorbent polymer, and the other thin layers and adhesion factors associated with the thin pulp wrapping layer far from the skin side are removed with an organic solvent that is not absorbed by the superabsorbent polymer, in order to extract the superabsorbent polymer from both the skin-side section and the body far from the skin side separately. (3) The superabsorbent polymers extracted from both the percutaneous and distal sections are weighed accurately to 1.000 g using an electronic balance (0.001 g sensitivity). If the quantity of superabsorbent polymer is insufficient, it is extracted from several top-layer absorbents of multiple absorbents in the same package, or from several top-layer absorbents of multiple absorbents packaged in the same carton. (4) Weighted superabsorbent polymers from both the skin-side and distal side sections are placed in separate nylon mesh bags, and the nylon mesh bags are sealed by thermal sealing. The nylon mesh bags are square bags with sides measuring 10 cm and are made of nylon mesh (250-hole nylon mesh (N-NO. 250HD, manufactured by NBC Meshtec)). Here below, the following steps are performed for each bag. (5) The mass of the bag containing sample (4) is measured using an electronic balance. The measured value is denoted by mass a. (6) Add 1000 ml of physiological saline solution to a 2-liter glass beaker. The physiological saline solution is an aqueous solution of sodium chloride with a concentration of 0.9%. (7) The bag is submerged so that it touches the bottom of the 2-liter cup in (6). (8) One side of the upper section of the bag is secured to the open rim of a 2-liter cup with a clothespin and left to stand for 1 hour. During this time, care is taken to minimize direct contact between the super-absorbent polymer and the nylon mesh. (9) After the bag is left to settle, it is lifted, a hole is made in the middle of the short side of the bag (5 mm from the top end and 50 mm from both ends) using a clothespin, and then it is drained for 15 minutes. (10) The mass of the drained bag is weighed using an electronic scale. The measured mass is denoted by b. (11) The filtered bag is dried using a centrifuge (model H130: manufactured by Kokusan Co. Ltd.). The conditions are: rotation speed 850 rpm (150 specific gravity) and duration: 90 seconds after reaching a constant rotation speed of 850 rpm. (12) The mass of the bag after drying is measured using an electronic scale. The measured value is denoted by mass C. (13) The water retention rate is calculated using the following formula: Water retention rate = C / B (g / g) Water absorption rate is calculated using the following formula: Water absorption rate B / A (g / g) (14) The number of tests is set at five, and their average is ultimately determined as the ability of each superabsorbent polymer to retain water. Examples Here, based on examples, the present invention will be described. However, the present invention is not limited to these examples. (1) Sample (a) Example 1 A sample is prepared in which the superabsorbent polymer in the central transverse section of the absorbent body (divided into three sections: two outer transverse sections and one central transverse section) of a 20 cm³ Lifree Refreshing Pad (of the same basic structure as the Light Incontinence Pad 1 described above) manufactured by Unicharm Corporation is replaced with a polymer containing the superabsorbent polymer 1 coated with an antibacterial agent. The superabsorbent polymer 1 coated with the antibacterial agent is prepared by dissolving the superabsorbent polymer in 0.3 mL of 1,3-butylene glycol containing 2% by mass of polyhexamethylene biguanide as the antibacterial agent and air-drying it for 24 hours. (b) Example 2 A sample is prepared by replacing the superabsorbent polymer in the central transverse section of a 20 cm³ Lifree Refreshing Pad with superabsorbent polymer 2 coated with an antibacterial agent. The superabsorbent polymer 2 coated with the antibacterial agent is prepared by dissolving the superabsorbent polymer in 0.3 mL of propylene glycol containing 2% by mass of benzalkonium chloride as the antibacterial agent and air-drying it for 24 hours. (c) Comparative example A sample is prepared in which the superabsorbent polymer in both the central section in the transverse direction and both outer sections in the transverse direction of the absorbent body is replaced with the top layer of a 20 cm3 Lifree Refreshing Pad with superabsorbent polymer 2 coated with an antibacterial agent. (2) Evaluation (1) Each of the samples from Example 1, Example 2, and the comparative example is stretched to the point where there are no wrinkles, and the perimeter of each sample is fixed to a glass plate with tape. (2) Each specimen is kept with the glass plate tilted in the transverse direction at a measuring angle of 30° with respect to the horizontal plane. (3) Add 10 mL of artificial urine three times per minute to a point at the center of each sample, both longitudinally and transversely, using a burette. Prepare the artificial urine by dissolving 200 g of urea; 80 g of sodium chloride (salt); 8 g of magnesium sulfate heptahydrate; 3 g of calcium chloride dihydrate; and 1 g of dye: Component Blue No. 1 [65% Blue No. 1 / 35% sodium chloride] in 10 L of ion-exchanged water, then stain. (4) Each sample is checked to see if artificial urine has leaked from the terminal section (lower side) in the transverse direction (whether or not lateral leakage has occurred). (3) Results In the samples in Example 1 and Example 2, no lateral leakage occurred. However, in the sample in the comparison, lateral leakage does occur. According to these results, it is evident that by using a superabsorbent polymer coated with an antibacterial agent only in the central section in the transverse direction, both antibacterial and lateral leakage properties can be achieved. The mild incontinence pads described in the present invention are not limited to the models described above. Suitable modifications or the application of known techniques may be made within the scope of the present invention, provided they do not conflict with its purpose and framework. Bookmarks list 1. Suction tool 4. Absorbent body

Claims

1. An absorbent article with alternating perpendicular longitudinal, transverse, and thickness directions, comprising an absorbent body bearing a superabsorbent polymer. It also includes an antibacterial liquid containing an antibacterial agent and an organic solvent. The antibacterial liquid is present in a larger quantity covering the superabsorbent polymer placed in a central section transversely aligned with the absorbent body, and in a smaller quantity covering the superabsorbent polymer placed on both outer sides of the central section transversely aligned with the absorbent body.

2. An absorbent article, according to protection element 1, also includes an absorbent body in the upper layer, comprising the absorbent body itself, and an absorbent body in the lower layer placed on the side furthest from the skin in the thickness direction relative to the absorbent body in the upper layer. 3.The absorbent article, according to protection element 2, contains a portion of antibacterial liquid in the absorbent body of the lower layer. The amount of antibacterial liquid in the absorbent body of the upper layer is greater than the amount of antibacterial liquid in the absorbent body of the lower layer.

4. The absorbent article, according to protection element 2 or 3, contains, in a horizontal projection, a superabsorbent polymer region (where the superabsorbent polymer is present) and a superabsorbent polymer-free region (where the superabsorbent polymer is absent). The superabsorbent polymer-free region includes a compressed section where the absorbent body of the upper layer is compressed in the thickness direction. 5.The absorbent article, according to which of the protection elements 2 to 3, must contain pulp fibers in at least the bottom layer of the absorbent body, the top layer, and the bottom layer, and the quantity of pulp fibers in the bottom layer of the absorbent body must be greater than the quantity of pulp fibers in the top layer of the absorbent body.

6. The absorbent article, according to which of the protection elements 2 to 5, must contain a greater quantity of antibacterial liquid covering the superabsorbent polymer placed in the central section in the longitudinal direction of the absorbent body, and a smaller quantity covering the superabsorbent polymer placed in front of the central section in the longitudinal direction of the absorbent body. 7.The absorbent article, according to any of the protection elements 2 to 6, includes an absorbent body in the upper layer consisting of a skin-side section positioned along the skin thickness and a distal section positioned away from the skin in relation to the skin-side section, with the water retention rate of the skin-side section being lower than that of the distal section. 8.The absorbent article, according to any of the protection elements 2 to 7, includes in the bottom layer an absorbent core; a thin core wrap sheet on the skin side covering the skin side in the direction of the absorbent core thickness; and a thin core wrap sheet away from the skin covering the side away from the skin in the direction of the absorbent core thickness. The thin core wrap sheet on the skin side and the thin core wrap sheet away from the skin are made of uneven crinkled paper, and the degree of unevenness in the thin core wrap sheet on the skin side is less than the degree of unevenness in the thin core wrap sheet away from the skin.